Vaxcyte is a clinical-stage vaccine innovation company focused on developing next-generation vaccines to prevent and treat infectious diseases. They are currently advancing vaccines for invasive pneumococcal disease, Group A Strep, periodontal disease, and Shigella. Vaxcyte leverages its XpressCFTM platform, a cell-free protein synthesis platform, to design and produce vaccines in ways that are believed to be superior to conventional technologies. As a biotech company, Vaxcyte is impacting the global health landscape by developing superior vaccines and offering them to the world. They are currently in the process of creating cutting edge vaccines to help combat deadly infectious diseases. Their work environment is guided by core values such as Rethinking Convention, Aiming High, Leading with Heart, and Modeling Excellence. Vaxcyte’s cell-free protein synthesis platform enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. Vaxcyte has a current tech stack of SPF, Microsoft Exchange Online, Office 365 Mail, Cloudflare Hosting, Microsoft Azure DNS, Cloudflare DNS, WP Engine, Smartsheet, Box, and Dropbox Business, which aids them in their pursuit of creating the most complex biologics. The company's team currently consists of 101-250 employees. They are a public company that has secured funding through post-IPO equity offerings, totaling $3.847 billion in funding rounds. Vaxcyte's stock is publicly traded on the NASDAQ under the symbol PCVX. This role is eligible for relocation assistance.

Datavant is a healthcare data logistics company that connects and moves data securely for organizations, providing solutions for data integration and collaboration.

Roivant Sciences is a biopharmaceutical company accelerating the development of promising late-stage drug candidates. We achieve this by building and supporting nimble, entrepreneurial biotech companies (Vants), leveraging a unique approach to talent acquisition, incentive alignment, and technology deployment. Our focus is on reducing the time and cost of bringing new medicines to market, ultimately improving patient lives and benefiting the healthcare system. We've successfully launched VTAMA®, achieved multiple FDA approvals, and secured significant global partnerships. This rapid growth has been fueled by strategic in-licensing, acquisitions, and a commitment to innovation. Our tech-enabled approach is central to our success. We utilize a robust technology stack including iPhone/Mobile compatibility, Google Tag Manager, Google Analytics, and a Content Delivery Network (CDN), ensuring efficient data management and streamlined operations. We foster a dynamic, collaborative environment, embracing both remote and in-person work models. Our engineering culture values agility, innovation, and a data-driven approach to problem-solving. Roivant's mission is to dramatically improve healthcare outcomes. We are a large company, currently employing between 501 and 1000 people, and we strive to create a rewarding and impactful workplace. We value both individual achievement and collaborative teamwork. We offer a range of exciting opportunities across multiple therapeutic areas, in both clinical development and tech-focused operations. Our significant funding and consistent success position us for continued growth and leadership in the biopharmaceutical industry. Roivant prioritizes diversity, equity, and inclusion. We are proud of our diverse workforce and offer a supportive and inclusive environment where every employee's contributions are valued. We embrace remote work, offering flexibility and empowering employees to perform at their best, regardless of location. With offices globally, we're a dynamic organization continually seeking talented and passionate individuals to join our mission.

Arcellx is a clinical-stage biotechnology company pioneering innovative cell therapies for cancer and other incurable diseases. Our lead product candidate, CART-ddBCMA, is in Phase 1 trials for multiple myeloma and has received FDA Fast Track, Orphan Drug, and Regenerative Medicine Advanced Therapy designations. We're also advancing our dosable and controllable CAR-T therapy, ARC-SparX, into clinical trials for multiple myeloma and acute myeloid leukemia. Arcellx is making significant strides in revolutionizing cell therapy, offering safer, more effective, and accessible treatments. We operate in a dynamic and rapidly evolving field, requiring a cutting-edge tech stack. Our team utilizes technologies such as Google Tag Manager, Google Font API, and leverages mobile-first design principles (iPhone/Mobile Compatible, Viewport Meta). We're committed to robust security (SSL by Default, SPF, DNSSEC, HSTS) and maintain a collaborative, innovative culture that values character, audacity, determination, collaboration, and originality. Our diverse and supportive environment empowers our employees to do their best work. Arcellx is a rapidly growing company with significant funding and a strong market position. We're a publicly traded company (NASDAQ: ACLX) with a workforce of 101-250 employees, dedicated to advancing humanity through safer and more effective cell therapies. We offer competitive salaries and benefits, including comprehensive health insurance, unlimited vacation, and generous parental leave. Join us in our mission to destroy cancer and advance humanity. Our commitment to excellence extends beyond our science. We cultivate a supportive and inclusive environment that fosters collaboration and innovation. Our teams are geographically distributed but highly connected, ensuring efficient communication and collaboration across projects.

Bruker BioSpin is a leading provider of scientific instruments and analytical solutions for life science research and industry applications, employing over 5,000 people.

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company at the forefront of precision medicine, developing life-changing medicines for patients with severe rare diseases and cancer. We are actively building our portfolio of targeted oncology drugs and are currently advancing two lead product candidates into late-stage clinical trials. Our strategic approach involves partnerships with industry and academia to unlock the full potential of our portfolio and create more solutions for patients with cancer. Our tech stack supports a collaborative and data-driven approach. We utilize technologies like Google Analytics, Google Tag Manager, and WordPress for our website presence, ensuring we have the tools for effective communication, data collection, and content management. Our engineering culture fosters collaboration and innovation to tackle complex challenges. We encourage cross-functional team work and expect our teams to contribute to the evolution of the company. We prioritize a culture that fosters growth, ownership, and community. SpringWorks Therapeutics is a rapidly growing company with between 251 and 500 employees. We offer a supportive, remote-friendly work environment, allowing our employees to work from home within the United States. As a public company listed on NASDAQ (SWTX), we have multiple funding rounds, and we are excited about our continued growth trajectory. Our commitment to DE&I and providing best-in-class benefits demonstrates our commitment to our SpringWorkers.

Ganymede is a low-code bio-aware PaaS for biotech software engineering, facilitating easy data integration and pipeline construction for software engineers in the biotech industry.

Simtra BioPharma Solutions is a leading pharmaceutical company specializing in the manufacturing of sterile injectables and clinical supplies. We partner with biotech and pharmaceutical companies, providing essential services for bringing life-changing medicines to patients worldwide. Our offerings include formulation development, lyophilization optimization, and global regulatory support, with a strong emphasis on quality and continuous improvement. With facilities in Bloomington, Indiana, US, and Halle/Westfalen, Germany, Simtra operates on a global scale, offering a diverse range of delivery systems, including pre-filled syringes, vials, and more. We're committed to making a tangible impact on patient health, and our teams thrive on collaboration, innovation, and exceeding expectations. As a company, we are driven to make it happen, make it together, make it right, and make it count. We are a company of over 1000 employees with a dedicated focus on employee well-being, offering comprehensive benefits packages. We're a forward-thinking organization committed to growth and innovation, and we offer opportunities for remote work. Simtra is proud to be an equal opportunity employer, and we encourage you to explore our current job openings.

Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies to address significant market opportunities, primarily in ophthalmic conditions. Our lead product candidate, TP-03, is a novel therapeutic currently in Phase 2b/3 clinical trials for the treatment of Demodex blepharitis, showcasing our commitment to addressing unmet medical needs. As a company of 101-250 employees, we leverage a robust tech stack including DNSSEC, Amazon Web Services (AWS) for cloud infrastructure, and BootstrapCDN for content delivery, ensuring a mobile-optimized experience for our users. We operate in a hybrid work environment and offer remote work options for many roles. Our culture thrives on commitment to patients, empowering innovation, and teamwork to amplify impact. We are a publicly traded company (NASDAQ:TARS), and our Series B funding round helped us to accelerate our research and development efforts. Our team is passionate about our mission to create category-creating products and is empowered to champion innovation. We have built a team of experts in ophthalmology and other therapeutic categories, with a focus on delivering on our promise to patients. Tarsus Pharmaceuticals is dedicated to attracting and retaining top talent by providing competitive compensation, including a comprehensive benefits package, stock equity and ensuring work-life balance through generous paid time off.

Dianthus Therapeutics is a clinical-stage biotechnology company pioneering novel monoclonal antibody treatments for severe autoimmune and inflammatory diseases. Our lead product, DNTH103, targets a specific part of the immune system and is designed for self-administration in some patients. We're making a significant impact in the biopharma industry by focusing on improved selectivity and potency, leading to more effective and targeted therapies. Our tech stack includes a robust mix of modern technologies such as Cloudflare JS, Google Cloud, and Cloudinary, reflecting our commitment to efficient and scalable development. We foster a collaborative engineering culture that embraces innovative approaches and prioritizes data-driven decision-making. We value scientific integrity, continuous learning, and a dedication to improving patient lives. We offer remote work opportunities and support a diverse and inclusive environment. Dianthus is a publicly traded company (NASDAQ: DNTH) with a strong funding history and a growing team of experienced professionals in biotech and pharma. We are actively expanding our team to support the advancement of DNTH103 through clinical trials and eventual commercialization. Join us in our mission to bring life-changing treatments to patients battling serious autoimmune diseases. We offer a supportive and flexible work environment which embraces remote work. Join our growing team and make a significant impact on the lives of patients suffering from autoimmune diseases. We are committed to providing transformative medicines for people living with severe autoimmune and inflammatory diseases.